Cargando…

Association Analysis of Hyperlipidemia with the 28-Day All-Cause Mortality of COVID-19 in Hospitalized Patients

OBJECTIVE: This study aimed to determine the association of hyperlipidemia with clinical endpoints among hospitalized patients with COVID-19, especially those with pre-existing cardiovascular diseases (CVDs) and diabetes. METHODS: This multicenter retrospective cohort study included all patients who...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Bin, Zhou, Jianghua, Wang, Wenxin, Yang, Huilin, Xia, Meng, Zhang, Binghong, She, Zhigang, Li, Hongliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Chinese Academy Medical Sciences. Published by Elsevier B.V. 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8041136/ https://www.ncbi.nlm.nih.gov/pubmed/33853705 http://dx.doi.org/10.24920/003866

Ejemplares similares

Looking beyond 28-day all-cause mortality
por: Rubenfeld, Gordon
Publicado: (2002)

Booster Vaccination Decreases 28-Day All-Cause Mortality of the Elderly Hospitalized Due to SARS-CoV-2 Delta Variant
por: Müller, Veronika, et al.
Publicado: (2022)

A Novel U-Shaped Association Between Serum Magnesium on Admission and 28-Day In-hospital All-Cause Mortality in the Pediatric Intensive Care Unit
por: Yue, Chao Yan, et al.
Publicado: (2022)

Risk factors associated with 28-day all-cause mortality in older severe COVID-19 patients in Wuhan, China: a retrospective observational study
por: Jiang, Yi, et al.
Publicado: (2020)

U-shaped association of serum uric acid with all-cause mortality in patients with hyperlipidemia in the United States: a cohort study
por: Huang, Lihua, et al.
Publicado: (2023)

Association between lactate-to-albumin ratio and 28-days all-cause mortality in patients with acute pancreatitis: A retrospective analysis of the MIMIC-IV database
por: Liu, Qiang, et al.
Publicado: (2022)

Predictive value of immune cell counts and neutrophil-to-lymphocyte ratio for 28-day mortality in patients with sepsis caused by intra-abdominal infection
por: Liu, Shuangqing, et al.
Publicado: (2021)

Trends of Stroke Incidence and 28-Day All-Cause Mortality after a Stroke in Malaysia: A Linkage of National Data Sources
por: Hwong, Wen Yea, et al.
Publicado: (2021)

Association between tocilizumab, sarilumab and all-cause mortality at 28 days in hospitalised patients with COVID-19: A network meta-analysis
por: Godolphin, Peter J., et al.
Publicado: (2022)

Reductions in 28-Day Mortality Following Hospital Admission for Upper Gastrointestinal Hemorrhage
por: Crooks, Colin, et al.
Publicado: (2011)

Impact of early hyperoxia on 28-day in-hospital mortality in patients with myocardial injury
por: Kim, Tae Yun, et al.
Publicado: (2018)

The predictive values of admission characteristics for 28-day all-cause mortality in septic patients with diabetes mellitus: a study from the MIMIC database
por: Yang, Chengyu, et al.
Publicado: (2023)

Predictive value of the serum anion gap for 28-day in-hospital all-cause mortality in sepsis patients with acute kidney injury: a retrospective analysis of the MIMIC-IV database
por: Jiang, Long, et al.
Publicado: (2022)

Development and validation of nomograms for predicting the risk probability of carbapenem resistance and 28-day all-cause mortality in gram-negative bacteremia among patients with hematological diseases
por: Jian, Xing, et al.
Publicado: (2023)

Thirty-Day Hospital Readmissions: A Predictor of Higher All-cause Mortality for Up to Two Years
por: Shaw, Jawaid A, et al.
Publicado: (2020)

Effects of Neutrophil-to-Lymphocyte Ratio Combined With Interleukin-6 in Predicting 28-Day Mortality in Patients With Sepsis
por: Liu, Shuangqing, et al.
Publicado: (2021)

Hyperlipidemia Caused by Voriconazole: A Case Report
por: Wu, Jiasheng, et al.
Publicado: (2021)

Association of serum total 25-hydroxy-vitamin D concentration and risk of all-cause, cardiovascular and malignancies-specific mortality in patients with hyperlipidemia in the United States
por: Chen, Xueqin, et al.
Publicado: (2022)

Hyperlipidemia and mortality in patients on peritoneal dialysis
por: Feng, Xiaoran, et al.
Publicado: (2022)

Day-To-Day Home Blood Pressure Variability and All-Cause Mortality in a Memory Clinic Population
por: Haverkamp, Rinske A., et al.
Publicado: (2022)

Relationship Between In-Hospital Adverse Events and Hospital Performance on 30-Day All-cause Mortality and Readmission for Patients With Heart Failure
por: Wang, Yun, et al.
Publicado: (2023)

Factors Associated within 28 Days In-Hospital Mortality of Patients with Acute Respiratory Distress Syndrome
por: Sharif, Nadia, et al.
Publicado: (2013)

SDF4 Is a Prognostic Factor for 28-Days Mortality in Patients With Sepsis via Negatively Regulating ER Stress
por: Zhu, Tingting, et al.
Publicado: (2021)

Activated protein C, severe sepsis and 28-day mortality
por: De La Torre-Prados, M, et al.
Publicado: (2012)

Trauma Early Mortality Prediction Tool (TEMPT) for assessing 28-day mortality
por: Kunitake, Ryan C, et al.
Publicado: (2018)

Development and Internal Validation of a New Prognostic Model Powered to Predict 28-Day All-Cause Mortality in ICU COVID-19 Patients—The COVID-SOFA Score
por: Moisa, Emanuel, et al.
Publicado: (2022)

Predictive value of soluble CD59 for poor 28-day neurological prognosis and all-cause mortality in patients after cardiopulmonary resuscitation: a prospective observatory study
por: Wang, Ling, et al.
Publicado: (2023)

Can heparin therapy reduce 28-day mortality in adult severe sepsis patients?
por: Jiang, Li-bing, et al.
Publicado: (2015)

Hospitalization rates and 30-day all-cause mortality among head and neck cancer patients and survivors with COVID-19
por: Hanna, Glenn J., et al.
Publicado: (2021)

Mortality of patients with hospital-onset sepsis in hospitals with all-day and non-all-day rapid response teams: a prospective nationwide multicenter cohort study
por: Hyun, Dong-gon, et al.
Publicado: (2022)

Trends in All-Cause Mortality across Gestational Age in Days for Children Born at Term
por: Wu, Chun Sen, et al.
Publicado: (2015)

Effect of Cardiovascular Risk Factors on 30-Day All-Cause Mortality in Cardiogenic Shock
por: Forner, Jan, et al.
Publicado: (2023)

Interpretable machine learning for predicting 28-day all-cause in-hospital mortality for hypertensive ischemic or hemorrhagic stroke patients in the ICU: a multi-center retrospective cohort study with internal and external cross-validation
por: Huang, Jian, et al.
Publicado: (2023)

Antithrombin use and 28-day in-hospital mortality among severe-burn patients: an observational nationwide study
por: Tagami, Takashi, et al.
Publicado: (2017)

Statins Are Associated with Improved 28-day Mortality in Patients Hospitalized with SARS-CoV-2 Infection
por: Memel, Zoe N., et al.
Publicado: (2021)

Albumin–Globulin Ratio Is an Independent Determinant of 28-Day Mortality in Patients with Critical Illness
por: Liu, Bin, et al.
Publicado: (2021)

Fentanyl- and midazolam-induced coma each influence days of mechanical ventilation and 28-day mortality
por: Tanios, Maged, et al.
Publicado: (2021)

The Association of Ageist Attitudes With All-Cause Hospitalizations and Mortality
por: Mohammed, Yaqub Nadeem, et al.
Publicado: (2019)

The Association Between Hyperlipidemia and In-Hospital Outcomes in Takotsubo Cardiomyopathy
por: Li, Pengyang, et al.
Publicado: (2021)

Association between lactate/albumin ratio and 28-day all-cause mortality in ischemic stroke patients without reperfusion therapy: a retrospective analysis of the MIMIC-IV database
por: Zhong, Yuan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sdj6vn9k8mobse170ua7gcdpfh